QTMeds

Drug Database Monograph

BYFAVO 20 mg

PENDING REVIEW

Active Ingredient: REMIMAZOLAM

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 68722379

← Back to Prescription Analyzer